XML 39 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 31,774 $ 186,138,466 $ 288,175 $ (169,523,815) $ 16,934,600
Balance (in shares) at Dec. 31, 2018 31,774,139        
Stock based compensation - employees, consultants and directors $ 0 227,658 0 0 227,658
Other comprehensive income, foreign translation adjustment 0 0 306,287 0 306,287
Proceeds from exercise of stock options $ 47 236,023 0 0 236,070
Proceeds from exercise of stock options (in shares) 46,734        
Cashless exercise of stock options $ 0 0 0 0 0
Cashless exercise of stock options (in shares) 967        
Cashless exercise of warrants $ 9 (9) 0 0 0
Cashless exercise of warrants (in shares) 9,029        
Issuance of restricted stock units $ 52 425,587 0 0 425,639
Issuance of restricted stock units (in shares) 51,817        
Proceeds from exercise of warrants $ 361 1,768,130 0 0 1,768,491
Proceeds from exercise of warrants (in shares) 360,358        
Net loss $ 0 0 0 (4,883,827) (4,883,827)
Balance at Mar. 31, 2019 $ 32,243 188,795,855 594,462 (174,407,642) 15,014,918
Balance (in shares) at Mar. 31, 2019 32,243,044        
Balance at Dec. 31, 2018 $ 31,774 186,138,466 288,175 (169,523,815) 16,934,600
Balance (in shares) at Dec. 31, 2018 31,774,139        
Balance at Dec. 31, 2019 $ 32,616 191,648,907 525,978 (188,789,459) 3,418,042
Balance (in shares) at Dec. 31, 2019 32,616,107        
Stock based compensation - employees, consultants and directors $ 0 729,429 0 0 729,429
Other comprehensive income, foreign translation adjustment 0 0 609,828 0 609,828
Proceeds from exercise of stock options $ 38 138,392 0 0 138,430
Proceeds from exercise of stock options (in shares) 38,277        
Issuance of restricted stock units $ 55 328,884 0 0 328,939
Issuance of restricted stock units (in shares) 54,734        
Issuance of common stock, net of fees incurred $ 3,421 19,538,200 0 0 $ 19,541,621
Issuance of common stock, net of fees incurred (in shares) 3,421,237       3,627,760
Net loss $ 0 0 0 (3,452,779) $ (3,452,779)
Balance at Mar. 31, 2020 $ 36,130 $ 212,383,812 $ 1,135,806 $ (192,242,238) $ 21,313,510
Balance (in shares) at Mar. 31, 2020 36,130,355